Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas.
Oncologist. 2013;18(3):271-2. doi: 10.1634/theoncologist.2012-0404. Epub 2013 Mar 13.
Oncologist. 2013.
PMID: 23485624
Free PMC article.
Clinical Trial.
A phase I study of ABT-510 plus bevacizumab in advanced solid tumors.
Uronis HE, Cushman SM, Bendell JC, Blobe GC, Morse MA, Nixon AB, Dellinger A, Starr MD, Li H, Meadows K, Gockerman J, Pang H, Hurwitz HI.
Uronis HE, et al. Among authors: cushman sm.
Cancer Med. 2013 Jun;2(3):316-24. doi: 10.1002/cam4.65. Epub 2013 Mar 21.
Cancer Med. 2013.
PMID: 23930208
Free PMC article.
Clinical Trial.
Item in Clipboard
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors.
Rangwala F, Bendell JC, Kozloff MF, Arrowood CC, Dellinger A, Meadows J, Tourt-Uhlig S, Murphy J, Meadows KL, Starr A, Broderick S, Brady JC, Cushman SM, Morse MA, Uronis HE, Hsu SD, Zafar SY, Wallace J, Starodub AN, Strickler JH, Pang H, Nixon AB, Hurwitz HI.
Rangwala F, et al. Among authors: cushman sm.
Invest New Drugs. 2014 Aug;32(4):700-9. doi: 10.1007/s10637-014-0089-2. Epub 2014 Apr 9.
Invest New Drugs. 2014.
PMID: 24711126
Free PMC article.
Clinical Trial.
Item in Clipboard
A phase II study of capecitabine, oxaliplatin, bevacizumab and cetuximab in the treatment of metastatic colorectal cancer.
Wong NS, Fernando NH, Nixon AB, Cushman S, Aklilu M, Bendell JC, Morse MA, Blobe GC, Ashton J, Pang H, Hurwitz HI.
Wong NS, et al.
Anticancer Res. 2011 Jan;31(1):255-61.
Anticancer Res. 2011.
PMID: 21273607
Free PMC article.
Clinical Trial.
Item in Clipboard
Gene expression markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance).
Cushman SM, Jiang C, Hatch AJ, Shterev I, Sibley AB, Niedzwiecki D, Venook AP, Owzar K, Hurwitz HI, Nixon AB.
Cushman SM, et al.
Clin Cancer Res. 2015 Mar 1;21(5):1078-86. doi: 10.1158/1078-0432.CCR-14-2313. Epub 2014 Dec 17.
Clin Cancer Res. 2015.
PMID: 25520391
Free PMC article.
Item in Clipboard
Control of RhoA methylation by carboxylesterase I.
Cushman I, Cushman SM, Potter PM, Casey PJ.
Cushman I, et al. Among authors: cushman sm.
J Biol Chem. 2013 Jun 28;288(26):19177-83. doi: 10.1074/jbc.M113.467407. Epub 2013 May 8.
J Biol Chem. 2013.
PMID: 23658012
Free PMC article.
Item in Clipboard
Everolimus Effect on Gastrin and Glucagon in Pancreatic Neuroendocrine Tumors.
Pavel ME, Chen D, He W, Cushman S, Voi M, de Vries EGE, Baudin E, Yao JC.
Pavel ME, et al.
Pancreas. 2017 Jul;46(6):751-757. doi: 10.1097/MPA.0000000000000830.
Pancreas. 2017.
PMID: 28609362
Clinical Trial.
Item in Clipboard
GLUT1 is adequate for glucose uptake in GLUT2-deficient insulin-releasing beta-cells.
Liang Y, Cushman SM, Whitesell RR, Matschinsky FM.
Liang Y, et al. Among authors: cushman sm.
Horm Metab Res. 1997 Jun;29(6):255-60. doi: 10.1055/s-2007-979032.
Horm Metab Res. 1997.
PMID: 9230344
Item in Clipboard
Cite
Cite